Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Looking for maximum cashback on groceries? Check out our top credit card recommendations that offer the best rewards.
24,442 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Foreclosure activity in April 2026 declined from March yet posted a double-digit year-over-year gain, underscoring on...
The AI era has investors torn between memory stocks and dedicated AI chip leaders. This guide breaks down how to deci...
With the 2026 World Cup drawing millions to North America, specific ETFs positioned benefit from a sharp travel uptic...
Citi lowers Lucid's price target to $14 following a disappointing Q1 2026 and the withdrawal of 2026 guidance, while ...
NVIDIA and Alphabet reveal divergent AI strategies, highlighting hardware rails versus cloud-powered services, and si...
A major fund trimmed its ACI Worldwide position, nudging the stock to trail the S&P 500 by a noticeable gap. This sto...
Crypto traders are watching SpaceX’s near-public listing for signs that pre-IPO perpetual futures could become a majo...
A cost gap between IVW and cheaper growth peers may quietly erode returns over time. This analysis breaks down fees, ...
Google reopens mobile real estate listings in a growing pilot, delivering property pages, tour requests and agent con...
A disciplined $100/month Bitcoin plan started in 2015 would have yielded about $632,000 by May 2026, according to Coi...
A fresh retirement rule laid out on a March 2026 podcast reframes how affluent savers think about income in retiremen...